SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

SERA

SERA PROGNOSTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001534969-26-000019
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard, non-controversial shareholder vote. The election of directors and auditor ratification are expected to pass. Monitor for any unexpected dissident activity or shareholder proposals in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
SERA ▲ +4.00% at T+60d
NEUTRAL call +4.00% · α vs SPY -0.78% · entry $2.00 → $2.08
Entry = T+0 close
Apr 24, 2026
via day close
T+1d
-1.00%
call -1.00% · α -0.51%
$1.98
settled 6mo ago
T+5d
-5.00%
call -5.00% · α -5.40%
$1.90
settled 6mo ago
T+20d
+7.50%
call +7.50% · α +2.54%
$2.15
settled 5mo ago
T+60d
+4.00%
call +4.00% · α -0.78%
$2.08
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Sera Prognostics, Inc. filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, primarily to elect three directors and ratify the appointment of Ernst & Young LLP as its independent auditor. This is a routine, non-contentious shareholder vote.

Key Financial Metrics

Vote
director election
Meeting
2026-06-04

Key Facts

  • The filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting.
  • Proposals include the election of three directors: Jeffrey T. Elliott, Kim Kamdar, Ph.D., and Sandra A.J. Lawrence.
  • The second proposal is to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm.
  • The meeting will be held virtually on June 4, 2026.

Financial Impact

Routine, no immediate financial impact.

governanceaudit fees

Risk Factors

  • Low risk of shareholder dissent on these routine matters.
  • Potential for minor governance scrutiny if any nominee has a controversial background.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001534969-26-000019
Document: 0001534969-26-000019-index-headers.html0001534969-26-000019
Document: 0001534969-26-000019-index.html0001534969-26-000019
Document: 0001534969-26-000019.txt0001534969-26-000019
11 reports for SERA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SERA — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$2.04awaiting T+60—$2.04 (−0.00%)
Oct 13, 2026
13d ago
144
NEUTRAL ★ 2/10
$2.07awaiting T+60—$2.04 (−1.45%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$2.10awaiting T+60—$2.04 (−2.86%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$2.03 $2.11▲ +3.94%▲ +0.98%$2.04 (+0.49%)
Jun 15, 2026
19w ago
Insider Cluster
BEARISH ★ 5/10
$1.86 $2.05▼ −10.22%▼ −9.22%$2.04 (−9.68%)
Jun 8, 2026
20w ago
144
NEUTRAL ★ 2/10
$2.13 $2.01▼ −5.63%▼ −9.45%$2.04 (−4.23%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$2.04 $2.09▲ +2.45%▲ +1.33%$2.04 (−0.00%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$2.00 $2.08▲ +4.00%▼ −0.78%$2.04 (+2.00%)
Mar 6, 2026
33w ago
Insider Cluster
NEUTRAL ★ 3/10
$1.95 $2.19▲ +12.31%▼ −0.47%$2.04 (+4.62%)
Mar 6, 2026
33w ago
Insider Cluster
NEUTRAL ★ 3/10
$1.95 $2.19▲ +12.31%▼ −0.47%$2.04 (+4.62%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 2h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026